Clinical Trial Update: Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety and efficacy of PF-06700841 in moderate-to-severe plaque psoriasis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• PF-06700841

Snippet

Sponsor: Pfizer | Conditions: Chronic Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2019-03-29